What are the side effects of Dapsone (Diaminodiphenyl Sulfone)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Dapsone's most concerning side effects include methemoglobinemia, hemolytic anemia, and agranulocytosis, which can lead to severe health complications, and therefore, patients should be closely monitored for these adverse effects, especially during the initial treatment phase. The side effects of Dapsone (Diaminodiphenyl Sulfone) can be severe and impact the patient's quality of life. According to the most recent study 1, Dapsone can cause methemoglobinemia, a condition where the blood carries less oxygen, leading to symptoms like cyanosis, headache, fatigue, and shortness of breath. Other significant side effects include:

  • Hemolytic anemia, particularly in patients with G6PD deficiency, which can lead to decreased red blood cell counts and jaundice
  • Agranulocytosis, reducing white blood cell counts and increasing infection risk
  • Dermatological reactions ranging from mild rashes to severe conditions like Stevens-Johnson syndrome
  • Peripheral neuropathy, which may develop with long-term use, causing numbness and weakness in extremities
  • Gastrointestinal issues like nausea, vomiting, and abdominal pain
  • Hepatotoxicity, presenting as elevated liver enzymes or jaundice As noted in the study 1, patients with G6PD deficiency are particularly at risk, and all patients at risk for G6PD deficiency should be screened before being treated. Additionally, patients should be monitored for the potential development of methemoglobin; in one trial, 5.7% reported having developed methemoglobinuria 1. In contrast to the older study 1, which reported dose-related hemolysis as the most common adverse effect, the more recent study 1 highlights the importance of monitoring for methemoglobinemia and hemolytic anemia, especially in patients with G6PD deficiency. Therefore, regular blood monitoring is crucial for patients on Dapsone, especially during the first few months of treatment, to detect any abnormalities early and prevent severe health complications.

From the FDA Drug Label

WARNINGS The patient should be warned to respond to the presence of clinical signs such as sore throat, fever, pallor, purpura or jaundice. Deaths associated with the administration of Dapsone have been reported from agranulocytosis, aplastic anemia and other blood dyscrasias. ADVERSE REACTIONS In addition to the warnings listed above, the following syndromes and serious reactions have been reported in patients on Dapsone. Hematologic Effects: Dose-related hemolysis is the most common adverse effect and is seen in patients with or without G6PD deficiency Almost all patients demonstrate the inter-related changes of a loss of 1-2g of hemoglobin, an increase in the reticulocytes (2-12%), a shortened red cell life span and a rise in methemoglobin. Body As A Whole: In addition to the warnings and adverse effects reported above, additional adverse reactions include: nausea, vomiting, abdominal pains, pancreatitis, vertigo, blurred vision, tinnitus, insomnia, fever, headache, psychosis, phototoxicity, pulmonary eosinophilia, tachycardia, albuminuria, the nephrotic syndrome, hypoalbuminemia without proteinuria, renal papillary necrosis, male infertility, drug-induced Lupus erythematosus and an infectious mononucleosis-like syndrome.

The side effects of Dapsone include:

  • Hematologic effects:
    • Dose-related hemolysis
    • Agranulocytosis
    • Aplastic anemia
    • Loss of 1-2g of hemoglobin
    • Increase in reticulocytes
    • Shortened red cell life span
    • Rise in methemoglobin
  • Nervous system effects:
    • Peripheral neuropathy
    • Motor loss
    • Muscle weakness
  • Body as a whole:
    • Nausea
    • Vomiting
    • Abdominal pains
    • Pancreatitis
    • Vertigo
    • Blurred vision
    • Tinnitus
    • Insomnia
    • Fever
    • Headache
    • Psychosis
    • Phototoxicity
    • Pulmonary eosinophilia
    • Tachycardia
    • Albuminuria
    • The nephrotic syndrome
    • Hypoalbuminemia without proteinuria
    • Renal papillary necrosis
    • Male infertility
    • Drug-induced Lupus erythematosus
    • An infectious mononucleosis-like syndrome
    • Cutaneous reactions, including bullous, exfoliative dermatitis, toxic erythema, erythema multiforme, toxic epidermal necrolysis, morbilliform and scarlatiniform reactions, urticaria and erythema nodosum 2, 2

From the Research

Side Effects of Dapsone

The side effects of Dapsone (Diaminodiphenyl Sulfone) include:

  • Hemolytic anemia 3, 4, 5
  • Methemoglobinemia 3, 4, 6, 7, 5
  • Agranulocytosis 3
  • Dyspnea 6, 7
  • Cyanosis 6, 7
  • Hypoxemia 4, 7

Factors Influencing Side Effects

The occurrence and severity of these side effects can be influenced by:

  • Dose of Dapsone 3
  • Presence of comorbidities such as anemia, chronic heart failure, and right pleural effusion 6
  • Concurrent events such as pneumonia 5
  • Level of methemoglobinemia 6, 5

Management of Side Effects

Management of Dapsone-induced methemoglobinemia typically involves:

  • Discontinuation of Dapsone 4, 6, 7
  • Administration of methylene blue 7, 5
  • Monitoring of methemoglobin levels and clinical symptoms 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Complications related to dapsone use for Pneumocystis jirovecii pneumonia prophylaxis in solid organ transplant recipients.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2005

Research

Dapsone-induced methemoglobinemia: a primer for clinicians.

The Annals of pharmacotherapy, 2011

Research

A Case of Dapsone-induced Mild Methemoglobinemia with Dyspnea and Cyanosis.

Acta dermatovenerologica Croatica : ADC, 2020

Research

Dapsone-induced methemoglobinemia.

The Annals of pharmacotherapy, 1998

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.